冠昊生物: 第六届董事会第十五次会议决议公告

Group 1 - The company has decided to terminate the issuance of shares to specific targets and withdraw the application documents due to changes in the market environment and overall development planning [1][2] - The board meeting was conducted with a combination of in-person and communication methods, with independent directors participating via communication [1] - The resolution regarding the termination of the share issuance was passed with 3 votes in favor, 0 against, and 0 abstentions, while 2 directors recused themselves from the vote [2] Group 2 - The company has established a "Management System for the Departure of Directors and Senior Management" to comply with the latest laws and regulations, aiming to enhance corporate governance [2] - The resolution for the management system was approved with 5 votes in favor, 0 against, and 0 abstentions [2]